IBA moves toward sale of Cisbio Bioassays

05/14/2013 | Reuters

Ion Beam Applications said it is in a tentative deal to sell its drug discovery unit Cisbio Bioassays to a private equity firm in Europe for $32.5 million. IBA said it is focusing on its core operations involving particle accelerators and radiation therapy. The deal is set to be completed in the coming months.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA